GAMMA Investing LLC Acquires New Stake in Astrana Health, Inc. (NASDAQ:ASTH)

GAMMA Investing LLC bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 580 shares of the company’s stock, valued at approximately $34,000.

Other large investors have also modified their holdings of the company. SG Americas Securities LLC purchased a new position in shares of Astrana Health in the third quarter worth about $680,000. Handelsbanken Fonder AB acquired a new stake in Astrana Health in the 3rd quarter valued at about $492,000. Granite Bay Wealth Management LLC acquired a new stake in Astrana Health in the 3rd quarter valued at about $290,000. Finally, Central Pacific Bank Trust Division purchased a new position in Astrana Health in the 3rd quarter worth approximately $160,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $60.59 on Friday. The business’s fifty day simple moving average is $53.14 and its 200-day simple moving average is $45.84. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. The firm has a market cap of $3.39 billion, a PE ratio of 45.90, a price-to-earnings-growth ratio of 2.20 and a beta of 1.21. Astrana Health, Inc. has a 52 week low of $28.86 and a 52 week high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The company had revenue of $486.30 million for the quarter, compared to analysts’ expectations of $440.68 million. During the same quarter in the prior year, the company posted $0.28 earnings per share. Astrana Health’s revenue for the quarter was up 39.7% compared to the same quarter last year. Equities analysts forecast that Astrana Health, Inc. will post 1.33 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ASTH shares. Truist Financial upped their price target on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Robert W. Baird upped their target price on Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a report on Thursday, August 15th. Stifel Nicolaus lifted their price target on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. BTIG Research upped their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Finally, TD Cowen began coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $62.00.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.